There is a growing body of preclinical and clinical evidence to support use of CBD oils for many conditions, suggesting its potential role as another option for treating challenging chronic pain or opioid addiction. Care must be taken when directing patients toward CBD products because there is little regulation, and studies have found inaccurate labeling of CBD and tetrahydrocannabinol quantities…Cannabidiol and hemp oils are nonintoxicating and potentially useful phytocannabinoid substances that continue to grow in popularity. With increasing patient interest in and use of CBD and hemp oils, more research is indicated to better understand their potential efficacy and purported safety profile. Careful selection of a product is crucial for both safety and potential efficacy.’ [read more]